U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 81 - 90 of 100

Medication First Approach for the treatment of Opioid Use Disorder (PDF - 189 KB KB)

This fact sheet provides an overview of the Medication First (or low-barrier maintenance pharmacotherapy) approach to the treatment of opioid use disorders.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Missouri Opioid State Targeted Response (STR)
Year
Resource Type
PDF

NIATx Buprenorphine Implementation Toolkit

Provides an overview of how organizations can use NIATx practices and tools to implement or improve a buprenorphine treatment program.

Format
Toolkit
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
Network for the Improvement of Addiction Treatment (NIATx)
Year

Bloomberg American Health Initiative - Fentanyl FORECAST Study (PDF - N/A KB)

An informational page on the Bloomberg American Health Initiative website which details facts and resources from their Fentanyl Overdose Reduction Checking Analysis Study (FORECAST).

Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
States
Source
John Hopkins Bloomberg School of Public Health
Year
Resource Type
Web Page

Fact Sheet: Fentanyl Testing to Prevent Overdose (PDF - 262 KB KB)

A fact sheet which includes information about fentanyl for both people who use drugs and Healthcare providers.

Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Patients
Other Team Members
Families
Source
Office of AIDS - California Department for Public Health (CDPH)
Year
Resource Type
PDF

Reducing Risk of Misuse and Diversion (PDF - .43 MB KB)

Describes strategies to help reduce the potential for misuse or diversion of medication for SUD treatment.

Format
Fact Sheet/Brochure
Audience
Medical Providers
Other Team Members
Source
Addiction Technology Transfer Center Network
Year

Safer-Use Strategies: Uppers/Stimulants (PDF - 80.2 KB KB)

Tips to help people stay safer and healthier no matter how they choose to change your use.
Format
Instrument/Protocol
Audience
Communities
Patients
Source
The Harm Reduction Research and Treatment (HaRRT) Center at the University of Washington
Year
Resource Type
PDF

Diversion and Abuse of Buprenorphine

Provides a high-level overview of the potential for buprenorphine abuse and how to reduce the risks.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Source
Providers Clinical Support System
Year

Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Families
Communities
Source
U.S. Food & Drug Administration (FDA)
Year
Resource Type
Web Page